Experiments were designed to test the hypothesis that elevated levels of endothelin 1 (ET-1) in the vasculature activate NADPH oxidase and/or uncoupled nitric-oxide synthase (NOS), resulting in O 2
was monitored by oxidized dihydroethidine staining and/or lucigenin chemiluminescence. ET-1 significantly increased O 2 .
production compared with vehicle. SOD, ebselen, and apocynin inhibited the ET-1-induced increase in O 2 . in intact and endothelium-denuded aorta. L-NAME and BH 4 inhibited the ET-1-induced increase in O 2 . in intact tissue, whereas these two compounds had no effect on ET-1-induced O 2 . in endotheliumdenuded aorta. Preincubation with BQ-123 or A-192621, individually, had no effect on ET-1-induced O 2 . ; however combining both antagonists inhibited the ET-1-stimulated increase in O 2 . .
Rat aortic rings were incubated with ET-1 or vehicle in the presence or absence of sepiapterin (BH 4 synthesis substrate) or apocynin and mounted on wire myographs to determine isometric force generation in response to increasing KCl concentrations. ET-1 increased the contractile response to KCl compared with vehicle. Treatment with either sepiapterin or apocynin attenuated the ET-1-mediated increase with no effect of sepiapterin or apocynin alone. These data support the hypothesis that ET-1 increases vascular tone, in part, through ET A /ET B receptor activation of O 2 . production from NADPH oxidase and NOS uncoupling.
Not long ago, O 2 . was considered simply a destructive byproduct of cellular reactions. However, it is becoming clear that O 2 . and other reactive oxygen species (ROS) play a role in maintaining cellular homeostasis and cell signaling (Wolin, 2000) . O 2 . is generated by virtually every cell type within the vascular wall (Madamanchi et al., 2005) . Furthermore, experimental animal models and clinical studies of atherosclerosis, hypertension, and diabetes have demonstrated increased vascular O 2 . and/or ROS production (for review see Griendling and FitzGerald, 2003; Madamanchi et al., 2005; Munzel et al., 2005) . Endothelial dysfunction and the bioavailability of nitric oxide (NO) have been documented as one of the many risk factors for cardiovascular disease. Several possible abnormalities may account for the dysfunction, including 1) reduced NO synthesis, 2) uncoupling of NO synthase (NOS) to produce O 2 . , and 3) degradation of NO via its interaction with O 2 . from other enzymatic sources. NOS uncoupling has been shown to occur when the NOS cofactor tetrahydrobiopterin (BH 4 ) is oxidized or in limited quantities (Vasquez-Vivar et al., 1998; Milstein and Katusic, 1999; Laursen et al., 2001) . It has been reported recently (Landmesser et al., 2003) (Beckman and Koppenol, 1996) . Recently, Kuzkaya et al. (2003) have reported that BH 4 is more sensitive to oxidation by ONOO Ϫ than O 2 . , suggesting that there is increased NOS uncoupling in the presence of ONOO Ϫ . Landmesser et al. (2003) suggested that activated NADPH oxidase is critical for producing ROS, which leads to the oxidation of BH 4 . Recently, it has been postulated that activated NADPH oxidase provides the priming event ("kindling" radicals), which may lead to NOS uncoupling and production of O 2
. or "bonfire" radicals within the endothelium and vascular wall (Munzel et al., 2005) . Endothelin (ET-1) is a potent endothelial-derived vasoconstrictor peptide. ET-1 is generally known to stimulate ET A receptors in vascular smooth muscle cells to produce vasoconstriction and ET B receptors on endothelial cells to produce vasodilation. The balance between ET A and ET B receptor activity may contribute to the pathogenesis of vascular disease (Ram, 2003; Kirchengast and Luz, 2005) . Some but not all experimental models of hypertension, atherosclerosis, and diabetes display high levels of circulating ET-1 and are associated with endothelial dysfunction (for review, see Bousette and Giaid, 2003; Cernacek et al., 2003; Muller et al., 2003; Schiffrin, 2005 (Dai et al., 2004; Dong et al., 2005 production is receptor subtype-dependent.
Materials and Methods
Materials. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. Optimum cutting temperature compound was purchased from VWR (West Chester, PA). NaCl, KCl, EDTA, and apocynin were purchased from Fisher Scientific Co. (Pittsburgh, PA). Endothelin-1 was purchased from American Peptide Co., Inc. (Sunnyvale, CA). Tetrahydro-L-biopterin was purchased from Cayman Chemical (Ann Arbor, MI). ET-1 receptor antagonists were kindly provided by Abbott Laboratories (Abbott Park, IL).
Isolation and Incubation of Rat Aortic Rings. Experiments were conducted in male Sprague-Dawley rats (Harlan, Indianapolis, IN) weighing 200 to 250 g. The institutional animal care and use committee approved all of the procedures. Rats were anesthetized with sodium pentobarbital (50 mg/kg i.p.; Abbott Laboratories), and thoracic aorta was removed, cleaned of adhering tissue in ice-cold physiological saline solution (PSS), and cut into 3-to 4-mm segments. Composition of PSS was as follows: 130 mM NaCl, 4.7 mM KCl, 1.8 mM KH 2 PO 4 , 1.17 mM MgSO 4 , 14.9 mM NaHCO 3 , 5.5 mM dextrose, 0.26 mM EDTA, and 1.6 mM CaCl 2 .
Measurement of ET-1-Mediated O 2 . Production with Lucigenin-Enhanced Chemiluminescence. Vessels were left intact or denuded of endothelium and incubated for 4 h at 37°C in either PSS (basal) or ET-1 (0.001-1 M) in siliconized polypropylene microcentrifuge tubes. Denudation of the aorta was accomplished by rubbing the tissue with blunt forceps. The denudation technique was verified in a subset of aortic tissue by testing the vascular reactivity of the aortic ring to constrict to phenylephrine (10 M) followed by testing the relaxation of the ring to acetylcholine (100 M). The denudation technique used demonstrated constriction to phenylephrine followed by a total absence of relaxation to acetylcholine, whereas the endothelium-intact tissue was fully relaxed. A subset of rings were preincubated for 1 h with one of the following inhibitors: superoxide dismutase (SOD; 300 U/ml), L-NAME (100 M), ebselen (50 M), . Background wells contained lucigenin solution without tissue. Lucigenin solutions were maintained in the dark. Plates were dark adapted for 30 min and counted on a TopCount scintillation and luminescence counter (PerkinElmer Life and Analytical Sciences) set to single photoncounting mode for 3 s/well. The counts were repeated eight times to reduce variability, averaged, and normalized to per minute (counts per minute). Background luminescence was subtracted, and the specific counts per minute were normalized to the dry weight of the tissue. The lucigenin method utilized in this study is a modified high-throughput method, which accommodates comparisons of multiple aortic segments simultaneously. Validation of the highthroughput method utilized a purified substrate/enzyme source of O 2 . , xanthine/xanthine oxidase, in the presence and absence of SOD.
In Situ Detection of ET-1-Mediated O 2 . Production. Vessels were incubated for 4 h at 37°C in either PSS (basal) or ET-1 (1 M) in siliconized polypropylene microcentrifuge tubes. A subset of rings was preincubated for 1 h with one of the following inhibitors: polyethylene glycol-SOD (PEG-SOD; 250 U/ml) or apocynin (300 M). Aortic rings were frozen in optimum cutting temperature compound media (Tissue-Tek; Sakura Finetechnical, Tokyo, Japan), cut on a cryostat (Cyrostat CM3000; Leica Microsystems, Inc., Deerfield, IL) into 30-m thick sections, and mounted on glass slides. Slides were protected from light and incubated in dihydroethidine (DHE; 1 M) for 30 min at 37°C. Images were obtained with a LSM 510 META confocal microscope (Carl Zeiss Inc., Thornwood, NY), with an excitation of 488 nm and emission of 574 to 595 nm or a 560-nm long pass filter. Vascular Reactivity. Aortic rings were incubated as previously outlined. Rings were mounted between pins in a multichamber myograph for the measurement of isometric force generation. The chamber was filled with warmed (37°C) gassed (95% O 2 , 5% CO 2 ) PSS. Tension was set to 25 mN, and the buffer was replaced with calciumfree PSS to determine the passive tension. ET-1 treatment resulted in the development of active tension, and in calcium-free buffer, passive tension was determined to be 10 Ϯ 1 mN. Once passive tension was established, cumulative doses of KCl (8 -100 mM) were 
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accomplished in calcium-replete PSS in the presence or absence of inhibitors. Force generation (in millinewtons) was monitored using a computer
Results
ET-1 increased O 2 . production in both endothelium-intact and endothelium-denuded aortic tissue using lucigeninenhanced chemiluminescent O 2 . detection (Fig. 1, A and B) .
Specificity of the assay was demonstrated by a significant reduction of the signal in the presence of SOD (Fig. 1, A and  B) . ET-1 significantly increased O 2 . at 0.1 and 1 M in endothelium-intact and denuded tissue. The endothelium-denuded segments seem to have a higher O 2 . production at 0.01 M ET-1; however, this failed to reach statistical significance (Fig. 1B) . Aortic tissue dissected from the same animal was used to directly compare the response to ET-1 in endothelium-intact and denuded rings. No significant difference was detected in the ET-1-stimulated O 2 . production between endothelium-intact and endothelium-denuded aortic tissue (Fig. 1C) .
ET-1-mediated O 2 . production was verified with the oxidative fluorescent dye DHE. Increased nuclear staining, indicating enhanced O 2 . production, is evident in the tissues incubated with ET-1 when compared with those incubated in PSS (Fig. 2, A and B) . The NADPH oxidase inhibitor apocynin and the antioxidant PEG-SOD prevented the increase in DHE staining (Fig. 2, C and D) . ET-1-increased O 2 . production in endothelium-intact aortic tissue was significantly inhibited in the presence of the NOS inhibitor L-NAME, the NOS cofactor BH 4 , and antioxidant ebselen (Fig. 3 , A, C, and E). To determine whether the endothelium was the source for the L-NAME-inhibitable O 2 . , the aortic tissue was endothelium-denuded before incubation with ET-1. ET-1-mediated O 2 . production in the endotheliumdenuded aortic tissue was inhibited only in the presence of ebselen (Fig. 3 , B, D, and F). ET-1-stimulated O 2 . production in endothelium-intact tissue was significantly inhibited in the presence of both specific ET-1 receptor antagonists (Fig. 4B ), whereas individually, the antagonists did not inhibit O 2 . production (Fig. 4A) . L-NAME, BH 4 , ebselen, BQ-123, or A-192621 had no effect on basal aortic tissue O 2 .
detection (data not shown). Aortic vasoconstriction was assessed by monitoring the increase in force generation by increasing KCl concentrations. Incubation of endothelium-intact aortic tissue with ET-1 increased the vasoconstriction in comparison with in- cubation with vehicle alone. The maximal increase in force to KCl in the vehicle-treated vessels was 90 Ϯ 5%, whereas in the ET-1-treated vessels, the increase in force was 118 Ϯ 11% (Fig. 5) . The NADPH oxidase inhibitor apocynin significantly decreased the maximal ET-1-induced vasoconstriction (68 Ϯ 16% increase in force). Since we observed that uncoupled NOS via oxidized BH 4 was a source of the O 2 . (Fig. 3) , we determined contractile responses to KCl in vessels pretreated with sepiapterin, a precursor in the salvage pathway for the synthesis of BH 4 . Sepiapterin also significantly decreased the maximal ET-1-induced vasoconstriction (83 Ϯ 18% increase in force). Apocynin and sepiapterin had no effect on vehicle-treated vessels (75 Ϯ 8 and 87 Ϯ 9% increase in force, respectively).
Discussion
The new findings of this study are that 1) ET-1 mediates O 2
. production through uncoupled NOS in an endotheliumdependent manner, 2) endothelium-independent O 2 . production stimulated by ET-1 does not seem to be via activation of uncoupled NOS, 3) ET-1 activation of O 2 .
production involves both ET A and ET B receptor subtypes in aortic tissue, and 4) two sources of O 2 . , NADPH oxidase and uncoupled NOS, contribute to increased vasoconstriction mediated by ET-1. Additionally, we have confirmed the previous findings that ET-1-stimulated O 2 . production is dependent on NADPH oxidase. The present study supports the hypothesis that ET-1 mediates O 2 . production from activated NADPH oxidase providing the kindling radicals to uncouple NOS and facilitate endothelial dysfunction in a mechanism similar to that proposed by Munzel et al. (2005) .
ET-1-Mediated O 2 . Production and NOS Uncoupling.
We used two methods of O 2 . detection in this study, lucigeninenhanced chemiluminescence and oxidized dihydroethidine staining. Specificity of both O 2 . detection methods was verified by the inclusion of SOD, PEG-SOD, or ebselen. Ebselen 
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is an antioxidant that has been reported to have thioredoxin reductase and/or glutathione peroxidase-like activity (Zhao et al., 2002) . The lucigenin method for O 2 . detection has been reported to reflect levels of O 2 . extracellularly and intracellularly, because lucigenin is cell-permeable (Munzel et al., 2002) . Interestingly, we found that both the endotheliumintact and endothelium-denuded aortic tissues were stimulated by ET-1 to generate O 2 . . No quantitative difference was detected between the O 2 . production in endothelium-intact and denuded tissue from the same animal. This led us to speculate that, regardless of whether the endothelium is present, ET-1 maximally stimulated O 2 . production.
The present study extended the findings of Li et al. (2003) that ET-1 increases O 2 . via NADPH oxidase activation by
showing that ET-1 also activates uncoupled NOS in an endothelium-dependent manner. Experimental evidence to determine whether NOS is uncoupled requires measurements of O 2 . that is inhibited by a nonspecific NOS inhibitor L-NNA or L-NAME (Munzel et al., 2002) . These inhibitors can block the transfer of electrons to either L-arginine or oxygen (Andrew and Mayer, 1999) . In our experiments, L-NAME inhibited the ET-1-mediated O 2 . production in the endotheliumintact but not denuded tissue. These results indicate that endothelial NOS is a source of ET-1-stimulated O 2 . . Landmesser et al. (2003) have suggested that uncoupled endothelial NOS, via oxidized BH 4 , is a source of O 2 . production in aortic tissue in the DOCA-salt treated rat. Therefore, exogenous BH 4 was added to the tissue to provide a source of reduced BH 4 for NOS (Cosentino and Luscher, 1999) . These data revealed that exogenous BH 4 prevented the ET-1-stimulated O 2 . production in the endothelium-intact tissue. BH 4
did not inhibit the ET-1-mediated O 2 . production in the en- (Galle et al., 2000; Wedgwood et al., 2001a; Wedgwood et al., 2001b; Sedeek et al., 2003; Laplante et al., 2005) . ET B receptor-mediated ROS production in cultured human umbilical vein endothelial cells has also been reported recently (Dong et al., 2005) . These authors demonstrated that apocynin inhibited the ET-1-mediated ROS production and endothelial cell proliferation, although the authors did not determine whether ET-1 stimulation also produced NOS uncoupling. The present study demonstrated that both ET A and ET B receptor signaling is critical for stimulation of O 2 . production in aortic tissue, which was a puzzling finding. However, it is plausible that ET-1 may activate NADPH oxidase through both ET A and ET B receptors since both receptor subtypes have been reported to increase O 2 . (Galle et al., 2000; Wedgwood et al., 2001a; Sedeek et al., 2003; Dai et al., 2004; Dong et al., 2005; Laplante et al., 2005) . NADPH oxidase is expressed in all cell types in aortic tissue. Thus, we would speculate that ET-1 mediates stimulation of NADPH oxidase via both ET A and ET B receptors on smooth muscle and endothelial cells, which produce the socalled kindling radicals to further cause oxidation of BH 4 , resulting in NOS uncoupling. We have hypothesized that this may result from some type of "cross-talk" between the ET receptor signaling pathways. Recently, Just et al. (2004) and Channon, 2004) . Neither apocynin nor sepiapterin affected the vasoconstriction in the absence of ET-1. Both apocynin and sepiapterin lowered maximal constriction when compared with ET-1 alone. Thus, functionally, these data indicate that ET-1-mediated increased constriction is facilitated through the products of both NADPH oxidase and uncoupled NOS. Perspectives. In the present study, aortic tissue was incubated with exogenous ET-1 to model pathological states in which there are high levels of ET-1, such as salt-sensitive hypertension, atherosclerosis, and diabetes (Lariviere et al., 1993; White et al., 1994; Bousette and Giaid, 2003; Cernacek et al., 2003; Muller et al., 2003) . ET-1 is known to be a paracrine factor and to act locally within a given tissue or cell type; thus, this ex vivo method models the paracrine effects of ET-1 within the vascular tissue. It is difficult to assess the local concentrations of ET-1 within any given tissue at different points in a pathological state. Elmarakby et al. (2004) reported that plasma ET-1 levels are increased approximately 10-fold in ET B receptor-deficient rats on a high-salt diet compared with wild-type rats on a high-salt diet. When the same rats are chronically treated with an ET A receptor antagonist, plasma ET-1 levels increase approximately100-fold compared with wild-type rats on a high-salt diet. Under conditions of reduced receptor availability, we reasoned that the tissue ET-1 would be "displaced" into the circulation. Thus, the plasma levels of ET-1 would be a reasonable approximation of the tissue levels, suggesting that tissue levels can become extremely high.
There are many pathological states in which the vasculature is exposed to high levels of ET-1 and endothelial dysfunction is present. These conditions may or may not be associated with chronic hypertension. Indeed, we reported recently that chronic ET-1 infusion in whole animals on a high-salt diet increased aortic O 2 . production as well as produced a hypertensive state (Elmarakby et al., 2005) . The NADPH oxidase inhibitor apocynin reduced vascular O 2 . production without affecting hypertension. Although the mechanisms of endothelial dysfunction may be unknown, it appears that O 2 . and/or ROS production from diverse enzymatic and cellular sources may be involved in many vascular pathologies (Munzel et al., 2005) . Our data are consistent with the hypothesis that ET-1 stimulates NADPH oxidase in all cell types of the vasculature as well as the uncoupling of NOS in the endothelium via the oxidation of BH 4 . These events translate to enhanced vasoconstriction and may contribute to vascular disorders. Future studies will focus on additional ET-1-mediated dysfunction of NOS regulatory pathways in the vasculature.
